The Food and Drug Administration (FDA) is offering a funding opportunity through the NARMS Cooperative Agreement Program to enhance antibiotic resistance surveillance in retail food specimens. This initiative aims to strengthen public health measures by improving the detection of antibiotic-resistant bacteria in food commodities and expanding sampling efforts across new sites. The program is critical for addressing public health threats posed by antibiotic resistance, with a total funding amount of up to $5 million available for fiscal year 2025, supporting approximately 35 cooperative agreements. Interested applicants, including higher education institutions, non-profits, and government entities, must submit their applications by April 1, 2027, and can reach out to Jenise McNair at jenise.mcnair@fda.hhs.gov for further information.